How we can help you navigate the Path to Success
Candidate Development
Optimal host and genetic design selected for biologics synthesis and secretion, avoiding impurities. Small molecule biosynthetic routes exemplified, analytical methods established, first customer material delivered.
Process Development
Strain and upstream/downstream process optimised. Pre-MCB established. Cost-competitive, reliable, scalable and robust bioprocesses ensure predictable manufacture of small and large molecules to customer specification. Material for pre-clinical, pre-formulation and stability testing.
GLP Toxicology Material
Drug substance prepared for formulation and toxicology studies, all documentation, materials and processes controlled through the QMS, ensuring traceability and full CMC compliance for regulatory submissions.
First in Human
Manufacture of drug substance using cGMP processes for First in Human clinical trials.
Read our Case Studies & Success Stories
Ingenza is a world class engineering biology company, providing rapid, efficient and cost effective methods including proprietary gene assembly, optimised recombinant production in microbial or mammalian hosts, and high throughput screening assays for your novel drug target.
Ingenza’s 13,500 sq ft facility in Edinburgh, Scotland fully integrates molecular biology, scalable fermentation, and a full analytical chemistry suite to deliver solutions for our biopharmaceutical customers.
— Dr John Runnacles, Business Research Director,Mitsubishi Chemical Methacrylates“We value our multi-year relationship with Ingenza, who have shown great capability and flexibility to help us successfully progress our technology development programme.”